• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    ProQR Therapeutics N.V. - Ordinary Shares (NQ:PRQR)

    1.650 +0.070 (+4.43%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 605,334
    Open 1.600
    Bid (Size) 1.660 (1,200)
    Ask (Size) 1.670 (300)
    Prev. Close 1.580
    Today's Range 1.600 - 1.740
    52wk Range 1.070 - 3.100
    Shares Outstanding 80,817,079
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook
    From ProQR Therapeutics N.V.
    Via GlobeNewswire
    News headline image
    ProQR to Participate in 8th Annual Evercore Healthcare Conference
    From ProQR Therapeutics N.V.
    Via GlobeNewswire

    Performance

    YTD
    -17.1%
    -17.1%
    1 Month
    -21.4%
    -21.4%
    3 Month
    -45.9%
    -45.9%
    6 Month
    -29.5%
    -29.5%
    1 Year
    -30.4%
    -30.4%

    More News

    Read More
    News headline image
    ProQR Announces Third Quarter 2025 Operating and Financial Results
    From ProQR Therapeutics N.V.
    Via GlobeNewswire
    News headline image
    ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025
    From ProQR Therapeutics N.V.
    Via GlobeNewswire
    News headline image
    Curious about the stocks that are showing activity after the closing bell on Thursday? ↗
    Via Chartmill
    News headline image
    ProQR to Participate in Upcoming Investor Conferences in October 2025
    From ProQR Therapeutics N.V.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    ProQR Announces Second Quarter 2025 Operating and Financial Results
    From ProQR Therapeutics N.V.
    Via GlobeNewswire
    News headline image
    ProQR Announces Upcoming Presentation at RNA Editing Summit
    From ProQR Therapeutics N.V.
    Via GlobeNewswire
    News headline image
    ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP
    From ProQR Therapeutics N.V.
    Via GlobeNewswire
    News headline image
    ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences
    From ProQR Therapeutics N.V.
    Via GlobeNewswire
    News headline image
    ProQR Announces First Quarter 2025 Operating and Financial Results
    From ProQR Therapeutics N.V.
    Via GlobeNewswire
    News headline image
    ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference
    From ProQR Therapeutics N.V.
    Via GlobeNewswire
    News headline image
    ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025
    From ProQR Therapeutics N.V.
    Via GlobeNewswire
    News headline image
    ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth
    From ProQR Therapeutics N.V.
    Via GlobeNewswire
    News headline image
    ProQR Announces Year End 2024 Operating and Financial Results
    From ProQR Therapeutics N.V.
    Via GlobeNewswire
    News headline image
    This Ralph Lauren Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
    Via Benzinga
    News headline image
    ProQR Therapeutics Announces $8.1 Million in New Funding from Rett Syndrome Research Trust to Expand RNA Editing Collaboration
    From ProQR Therapeutics N.V.
    Via GlobeNewswire
    News headline image
    ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist
    From ProQR Therapeutics N.V.
    Via GlobeNewswire
    News headline image
    ProQR Therapeutics to Host Virtual Analyst and Investor Event on December 11, 2024
    From ProQR Therapeutics N.V.
    Via GlobeNewswire
    News headline image
    Neurogene, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    ProQR Announces Third Quarter 2024 Operating and Financial Results
    From ProQR Therapeutics N.V.
    Via GlobeNewswire
    News headline image
    This First Solar Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗
    Via Benzinga
    News headline image
    ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement
    From ProQR Therapeutics N.V.
    Via GlobeNewswire
    News headline image
    ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement
    From ProQR Therapeutics N.V.
    Via GlobeNewswire

    Frequently Asked Questions

    Is ProQR Therapeutics N.V. - Ordinary Shares publicly traded?
    Yes, ProQR Therapeutics N.V. - Ordinary Shares is publicly traded.
    What exchange does ProQR Therapeutics N.V. - Ordinary Shares trade on?
    ProQR Therapeutics N.V. - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for ProQR Therapeutics N.V. - Ordinary Shares?
    The ticker symbol for ProQR Therapeutics N.V. - Ordinary Shares is PRQR on the Nasdaq Stock Market
    What is the current price of ProQR Therapeutics N.V. - Ordinary Shares?
    The current price of ProQR Therapeutics N.V. - Ordinary Shares is 1.650
    When was ProQR Therapeutics N.V. - Ordinary Shares last traded?
    The last trade of ProQR Therapeutics N.V. - Ordinary Shares was at 01/16/26 04:00 PM ET
    What is the market capitalization of ProQR Therapeutics N.V. - Ordinary Shares?
    The market capitalization of ProQR Therapeutics N.V. - Ordinary Shares is 133.35M
    How many shares of ProQR Therapeutics N.V. - Ordinary Shares are outstanding?
    ProQR Therapeutics N.V. - Ordinary Shares has 133M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.